{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:08:31Z","timestamp":1792264111836,"version":"4.4.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To examine temporal trends in cervical cancer screening practices and associated downstream abnormalities and procedures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>Women aged 18\u201364 years with commercial insurance or Medicaid insurance from 2008 to 2019 were identified using the IBM MarketScan databases. The annual rates of screening overall and by type of test (cytology, co-testing, or primary human papillomavirus testing) were examined. Downstream abnormal cytologic and histologic test results, colposcopies, and excisional procedures were examined, and rates were reported for the population of eligible patients with continuous insurance and for those who underwent screening. Changes over time in testing and outcomes were compared using \u03c7<jats:sup>2<\/jats:sup> tests and Spearman's correlation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>From 2008 to 2019, the annual screening prevalence decreased from 42.6% to 29.4% in women with commercial insurance (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001) and from 27.9% to 12.4% among women with Medicaid insurance (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001). In the cohort of women with commercial insurance, cytology usage decreased from 79.4% to 38.9% and co-testing increased from 20.1% to 59.6% (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001). Per 1,000 women screened, the rate of abnormal histologic and cytologic test results rose from 96 to 119 (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001) and colposcopies rose from 33 to 42 (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001); excisional procedures remained relatively constant. Per 1,000 eligible women, the rate of abnormal histologic and cytologic test results decreased from 41 to 35 (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001), colposcopies declined from 14 to 12, and excisional procedures decreased from 3 to 2.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Human papillomavirus testing has been rapidly incorporated into cervical cancer screening and is associated with an increasing trend of downstream abnormalities and procedures among screened women but a declining trend at the population level.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000004838","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T22:00:58Z","timestamp":1655157658000},"page":"55-64","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Temporal Trends in Cervical Cancer Screening Practices and Associated Downstream Abnormalities and Procedures Among Women With Insurance in the United States"],"prefix":"10.1097","volume":"140","author":[{"given":"Lillian","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Gockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn M.","family":"St Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Y.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady","family":"Khoury-Collado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Accordino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American cancer society guideline for the early detection of cervical neoplasia and cancer","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"R3-20250423","first-page":"417","article-title":"Cervical cytology screening. ACOG Practice Bulletin No. 45 [withdrawn]. American College of Obstetricians and Gynecologists","volume":"102","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R4-20250423","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement [published erratum appears in Ann Intern Med 2013;158:852]","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"R6-20250423","first-page":"e111","article-title":"Cervical cancer screening and prevention","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer us preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pmedr.2018.01.010","article-title":"Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003\u20132014","volume":"9","author":"Watson","year":"2018","journal-title":"Prev Med Rep"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/jwh.2018.7380","article-title":"Trends over time in pap and pap-HPV cotesting for cervical cancer screening","volume":"28","author":"MacLaughlin","year":"2019","journal-title":"J Womens Heal"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ygyno.2021.08.023","article-title":"Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013\u20132019","volume":"163","author":"Qin","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2018.10400","article-title":"Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US preventive services task force","volume":"320","author":"Melnikow","year":"2018","journal-title":"JAMA"},{"key":"R14-20250423","first-page":"743","article-title":"The psychosocial impact of human papillomavirus testing in primary cervical screening-a study within a randomized trial","volume":"18","author":"Kitchener","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13510","article-title":"ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening","volume":"13","author":"Kitchener","year":"2009","journal-title":"Health Technol Assess"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18230","article-title":"The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds","volume":"18","author":"Kitchener","year":"2014","journal-title":"Health Technol Assess"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","article-title":"Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial","volume":"7","author":"Ronco","year":"2006","journal-title":"Lancet Oncol"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial","volume":"98","author":"Ronco","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R19-20250423","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2017.19872","article-title":"Screening for cervical cancer in primary care: a decision analysis for the US preventive services task force","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"e015867","DOI":"10.1136\/bmjopen-2017-015867","article-title":"Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials","volume":"7","author":"Lehtinen","year":"2017","journal-title":"BMJ Open"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/bjc.2015.474","article-title":"HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study","volume":"114","author":"Palmer","year":"2016","journal-title":"Br J Cancer"},{"key":"R24-20250423","doi-asserted-by":"crossref","first-page":"415","DOI":"10.15585\/mmwr.mm7012a2","article-title":"Declines in prevalence of human papillomavirus vaccine-type infection among females after introduction of vaccine\u2014United States, 2003-2018","volume":"70","author":"Rosenblum","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"e2115321","DOI":"10.1001\/jamanetworkopen.2021.15321","article-title":"Modeling cervical cancer screening strategies with varying levels of human papillomavirus vaccination","volume":"4","author":"Grimes","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R26-20250423","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/LGT.0000000000000514","article-title":"Trends in patient demographics and diagnostic yield at an academic colposcopy clinic from 2008 to 2018","volume":"24","author":"Manning-Geist","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"R27-20250423","first-page":"50","article-title":"Trends in the diagnosis of high-grade cervical abnormalities in young women in the post-vaccination era","volume":"133","author":"Goyani","year":"2020","journal-title":"N Z Med J"},{"key":"R28-20250423","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/1471-0528.16250","article-title":"The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study","volume":"127","author":"Tidy","year":"2020","journal-title":"BJOG"},{"key":"R29-20250423","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/1471-0528.14562","article-title":"Reduction in colposcopy workload and associated clinical activity following human papillomavirus (HPV) catch-up vaccination programme in Scotland: an ecological study","volume":"124","author":"Cruickshank","year":"2017","journal-title":"BJOG"},{"key":"R30-20250423","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/pon.2003","article-title":"The psychosocial impact of an abnormal cervical smear result","volume":"21","author":"Drolet","year":"2012","journal-title":"Psychooncology"},{"key":"R31-20250423","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ygyno.2013.05.037","article-title":"Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer","volume":"130","author":"Tergas","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R32-20250423","doi-asserted-by":"crossref","first-page":"e218373","DOI":"10.1001\/jamanetworkopen.2021.8373","article-title":"Overuse of cervical cancer screening tests among women with average risk in the United States from 2013 to 2014","volume":"4","author":"Wright","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R34-20250423","first-page":"632","article-title":"Cervical cancer incidence and mortality among non-Hispanic African American and white women, United States, 1999\u20132015","volume":"112","author":"Gopalani","year":"2020","journal-title":"J Natl Med Assoc"},{"key":"R35-20250423","first-page":"591","article-title":"Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013\u2014United States","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R36-20250423","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.15585\/mmwr.mm7035a1","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2020","volume":"70","author":"Pingali","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R37-20250423","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/AOG.0000000000001804","article-title":"Cervical cancer screening guideline adherence before and after guideline changes in Pennsylvania Medicaid","volume":"129","author":"Parekh","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R38-20250423","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/AOG.0000000000001895","article-title":"Single health system adherence to 2012 cervical cancer screening guidelines at extremes of age and posthysterectomy","volume":"129","author":"Teoh","year":"2017","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:00:48Z","timestamp":1745431248000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004838","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"assertion":[{"value":"2021-12-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}